Biocon Ltd

Biocon | 532523

Market Closed

₹420.95

+₹0.00 (+2.38%)

As on 18/11/25, 9:43 PM

Market Cap54,969.26 CR

Current Price₹420.95

High / Low₹423.1 / 291

PE Ratio40.43

Book Value₹180.27

Dividend Yield0.15%

ROCE6.86%

ROE0.40%

Face Value₹2.00

Current Vol.37,40,504

Average Vol.12,76,53,456

ISININE376G01013

PB Ratio1.89

Debt to Equity0.84

Net Profit Margin9.37

Operating Margin29.3

Stock cgart

Stock Performance

₹2,480₹2,490

₹2,500

Previous CloseToday's Open

₹1,800₹3,000

₹2,500

52W Low52W High

₹2,480Today's Open

₹2,490Previous Close

12,00,000Volume

₹1,80052W Low

₹3,00052W High

Ratios

No data available

About Company

Biocon Limited is India's largest and fully-integrated, innovation-led biopharmaceutical company
At present, Company is engaged in the manufacture of biotechnology products and research services
Biocon Limited was incorporated in 1978 as a joint venture between Biocon Biochemicals Limited of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw
Biocon manufactured and exported enzymes to USA and Europe during the year 1979, as first of its kind
In 1989, Unilever plc acquired the Biocon Biochemicals Limited in Ireland and merges it with its subsidiary, Quest International
Also in the same year, the company had received US funding for proprietary technologies
After a year, in 1990, Biocon had scaled up its in-house research programme, based on a proprietary solid substrate fermentation technology, from pilot to plant level
Biocon's R&D and manufacturing facilities received ISO 9001 certification from RWTUV, Germany during the period of 1993
In the year 1994, the company had established the Syngene International Pvt
as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

;

Technical Indicators

RSI77.14

SMA 20380.12

SMA 50365.54

SMA 100368.08

SMA 200353.63

SMA 10394.55

MACD_12_26_Days14.02

EMA10Day398.08

EMA20Day385.29

EMA50Day372.00

MACD_12_26_9_Days4.65

EMA100Day365.28

EMA200Day356.79

Pivot Points

Volume Analysis

Growth Rate

Revenue Growth3.43%

ROE6.90%

EBITDA Margin29.30%

All figures in ₹ Crores

Indicators	2025	2024	2023	2022	2021
Revenue	15,261.70	14,755.70	11,174.20	8,184.00	7,143.10
Interest	897.40	974.40	419.00	67.60	57.70
Expenses	12,095.40	11,541.20	8,829.50	6,420.70	5,569.70
Financing Profit	4,374.50	4,080.00	2,720.60	1,976.00	1,827.90
Financing Margin %	29%	28%	24%	24%	26%
Other Income	1,208.20	865.50	375.90	212.70	254.50
Depreciation	1,687.00	1,568.80	1,113.10	814.20	715.10
Profit before tax	1,886.60	1,525.20	897.10	983.10	1,067.70
Tax %	24%	15%	28%	22%	21%
Net Profit	1,429.40	1,297.80	643.00	771.60	846.20
EPS in Rs	8.46	8.55	3.88	5.44	6.24

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
ISHARES CORE MSCI EMERGING MARKETS ETF	14 Nov ‘22	Purchase	5,00,049	₹281.05	18.78%
ISHARES CORE EMERGING MARKETS MAURITIUS CO	14 Nov ‘22	Sell	5,00,049	₹281.05	18.78%
ISHARES CORE MSCI EMERGING MARKETS ETF	03 Nov ‘22	Purchase	5,00,049	₹268.45	9.44%
ISHARES CORE EMERGING MARKETS MAURITIUS CO	03 Nov ‘22	Sell	5,00,049	₹268.45	9.44%
ISHARES CORE EMERGING MARKETS MAURITIUS CO	03 Oct ‘22	Sell	5,37,633	₹290.95	32.47%
ISHARES CORE MSCI EMERGING MARKETS ETF	03 Oct ‘22	Purchase	5,37,633	₹290.95	32.47%
ISHARES MSCI INDIA ETF	08 Aug ‘22	Purchase	4,96,327	₹313.3	49.37%
ISHARES INDIA INDEX MAURITIUS COMPANY	08 Aug ‘22	Sell	4,96,327	₹313.3	49.37%
ISHARES MSCI EMERGING MARKETS ETF	04 Oct ‘21	Purchase	3,76,635	₹365	21.72%
ISHARES EMERGING MARKETS INDEX MAURITIUS CO	04 Oct ‘21	Sell	3,76,635	₹365	21.72%

News

12 Nov 2025 12:00 am

Biocon reports consolidated net profit of Rs 84.50 crore in the September 2025 quarter

12 Nov 2025 12:00 am

Biocon Ltd spurts 1.95%, up for third straight session

Record Date

Corporate Action

Information

Announcement Day

08 Aug 2025

AGM

08 May 2025

04 Jul 2025

Final Dividend (₹0.5)

Recommended a final dividend at the rate of 10% i.e. Re. 0.50/- per equity share of face value of Rs. 5/- each for the financial year ended March 31, 2025, subject to Shareholders' approval at the ensuing Annual General Meeting ('AGM'). Pursuant to Regulation 42 of SEBI Listing Regulations, the Company has fixed Friday, July 04, 2025 as the record date for determining entitlement of Members to final dividend for the financial year ended March 31, 2025. The dividend will be paid on or before September 05, 2025.

08 May 2025

09 Aug 2024

AGM

16 May 2024

05 Jul 2024

Final Dividend (₹0.5)

Recommended a final dividend at the rate of 10% i.e. Re. 0.50/- per equity share of face value of Rs. 5/- each for the financial year ended March 31, 2024, subject to shareholders' approval at the ensuing Annual General Meeting (AGM'). Pursuant to Regulation 42 of SEBI Listing Regulations, the Company has fixed Friday, July 5, 2024 as the record date for determining entitlement of Members to final dividend for the financial year ended March 31, 2024. The dividend will be paid on or before September 6, 2024.

16 May 2024

11 Aug 2023

AGM

23 May 2023

07 Jul 2023

Final Dividend (₹1.5)

The Board recommended a final dividend at the rate of 30% i.e. Rs. 1.50/- per equity share of face value of Rs. 5/- each for the financial year ended March 31, 2023, subject to shareholders' approval at the ensuing Annual General Meeting ('AGM'). Pursuant to Regulation 42 of SEBI Listing Regulations, the Company has fixed Friday, July 7, 2023 as the record date for determining entitlement of members to final dividend for the financial year ended March 31, 2023. The dividend will be paid on or before September 8, 2023.

23 May 2023

28 Jul 2022

AGM

28 Apr 2022

01 Jul 2022

Final Dividend (₹0.5)

Board Recommended a final dividend at the rate of 10% i.e. Re. 0.50/- per equity share of face value of Rs. 5/- each for the financial year ended March 31, 2022, subject to shareholders' approval at the ensuing Annual General Meeting (AGM') and record date for payment of final dividend is July 1, 2022. The dividend will be paid within 30 (thirty) days from the date of shareholders' approval at the ensuing 44th AGM.

28 Apr 2022

23 Jul 2021

AGM

28 Apr 2021

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
422	56,366	120	2	25	1	9.37%
1,760	4,22,211	37	5	30	0	20.88%
6,475	1,71,898	69	11	59	0	23.41%
3,793	1,28,372	59	15	43	1	16.60%
1,515	1,22,349	22	4	19	0	19.21%
1,244	1,03,789	18	3	14	0	17.54%
2,047	93,506	22	5	17	0	14.56%
928	93,404	19	4	15	0	19.86%
2,224	91,800	53	6	35	0	14.39%
1,240	72,630	21	2	14	0	10.98%

Showing 10 of 124 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

Frequently Asked Questions

What is Share Price of Biocon Ltd?

The current share price of Biocon Ltd (Biocon) is ₹420.95. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Biocon Ltd?

The Price-to-Earnings (P/E) ratio of Biocon Ltd is 420.95. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Biocon Ltd?

Biocon Ltd has a 52-week high of ₹423.10 and a 52-week low of ₹291.00. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Biocon Ltd?

Biocon Ltd offers a dividend yield of 0.11%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Biocon Ltd?

The Earnings Per Share (EPS) of Biocon Ltd is ₹3.51. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Biocon Ltd?

Biocon Ltd has a Return on Equity (ROE) of 0.40%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds.